Alexion Pharmaceuticals, Inc.

Bank of New York Mellon Corp ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/11/2021

Shares

1,826,157

Value ($000)

335,483

Weight

0.1%

2013 Q4 - 2021 Q2 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/11/2021	335,483	0.1%	1,826,157	6/30/2021
2021 Q1	5/13/2021	277,327	0.1%	1,813,666	3/31/2021
2020 Q4	2/9/2021	299,819	0.1%	1,918,977	12/31/2020
2020 Q3	11/12/2020	202,888	0.1%	1,773,016	9/30/2020
2020 Q2	8/12/2020	188,466	0.1%	1,679,155	6/30/2020
2020 Q1	5/6/2020	149,144	0.0%	1,661,056	3/31/2020
2019 Q4	2/14/2020	179,120	0.0%	1,656,218	12/31/2019
2014 Q1	5/14/2014	395,340	0.1%	2,598,705	3/31/2014
2013 Q4	2/12/2014	346,305	0.1%	2,606,071	12/31/2013